Ventricular fibrillation frequency from implanted cardioverter defibrillator devices

Europace

Volumn 11, Issue 8, 2009, Pages 1052-1056

  Panfilov, Ilia ^a   Lever, Nigel A ^b,c   Smaill, Bruce H ^c,d   Larsen, Peter D ^e  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b AUCKLAND CITY HOSPITAL   (New Zealand)

^c THE UNIVERSITY OF AUCKLAND   (New Zealand)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Dominant frequency; Implantable cardioverter defibrillator; Ventricular fibrillation

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROGRAPHY; FEMALE; FOURIER TRANSFORMATION; HEART ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; CHILD; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME; VENTRICULAR FIBRILLATION; YOUNG ADULT;

EID: 68649121149     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eup159     Document Type: Article

References (22)

1. Jalife J. Ventricular fibrillation: mechanisms of initiation and maintenance. Annu Rev Physiol 2000;62:25-50.
2. Ten Tusscher KH, Hren R, Panfilov AV. Organization of ventricular fibrillation in the human heart. Circ Res 2007;100:e87-101.
3. Nash MP, Mourad A, Clayton RH, Sutton PM, Bradley CP, Hayward M et al. Evidence for multiple mechanisms in human ventricular fibrillation. Circulation 2006; 114:536-42.
4. Nanthakumar K, Walcott GP, Melnick S, Rogers JM, Kay MW, Smith WM et al. Epicardial organization of human ventricular fibrillation. Heart Rhythm 2004;1: 14-23.
5. Zaitsev AV, Berenfeld O, Mironov SF, Jalife J, Pertsov AM. Distribution of excitation frequencies on the epicardial and endocardial surfaces of fibrillating ventricular wall of the sheep heart. Circ Res 2000;86:408-17.
6. Moreno J, Zaitsev AV, Warren M, Berenfeld O, Kalifa J, Lucca E et al. Effect of remodelling, stretch and ischaemia on ventricular fibrillation frequency and dynamics in a heart failure model. Cardiovasc Res 2005;65:158-66.
7. Strohmenger H-U, Eftestol T, Sunde K, Wenzel V, Mair M, Ulmer H et al. The predictive value of ventricular fibrillation electrocardiogram signal frequency and amplitude variables in patients with out-of-hospital cardiac arrest. Anesth Analg 2001;93:1428-33.
8. Hillebrenner MG, Eason JC, Trayanova NA. Mechanistic inquiry into decrease in probability of defibrillation success with increase in complexity of preshock reentrant activity. Am J Physiol Heart Circ Physiol 2004;286:H909-17.
9. Newton JC, Johnson PL, Justice RK, Smith WM, Ideker RE. Estimated global epicardial distribution of activation rate and conduction block during porcine ventricular fibrillation. J Cardiovasc Electrophysiol 2002;13:1035-41.
10. Caldwell J, Burton FL, Smith GL, Cobbe SM. Heterogeneity of ventricular fibrillation dominant frequency during global ischemia in isolated rabbit hearts. J Cardiovasc Electrophysiol 2007;18:854-61.
11. Carlisle EJF, Allen JD, Kernohan WG, Leahey W, Adgey AAJ. Pharmacological analysis of established ventricular fibrillation. Br J Pharmacol 1990;100:530-4.
12. Clayton RH, Murray A, Campbell RW. Analysis of the body surface ECG measured in independent leads during ventricular fibrillation in humans. Pacing Clin Electrophysiol 1995;18:1876-81.
13. Nanthakumar K, Huang J, Rogers JM, Johnson P, Newton JC, Walcott GP et al. Regional differences in ventricular fibrillation in the open-chest porcine left ventricle. Circ Res 2002;91:733-40.
14. Newton JC, Smith WM, Ideker RE. Estimated global transmural distribution of activation rate and conduction block during porcine and canine ventricular fibrillation. Circ Res 2004;94:836-42.
15. Panfilov AV. Is heart size a factor in ventricular fibrillation? Or how close are rabbit and human hearts? Heart Rhythm 2006;3:862-4.
16. Anthony R, Daubert JP, Zareba W, Andrews ML, McNitt S, Levine E et al. Mechanisms of ventricular fibrillation initiation in MADIT II patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol 2008;31:144-50.
17. Lever NA, Newall EG, Larsen PD. Differences in the characteristics of induced and spontaneous episodes of ventricular fibrillation. Europace 2007;9:1054-8.
18. Taneja T, Goldberger J, Parker MA, Johnson D, Robinson N, Horvath G et al. Reproducibility of ventricular fibrillation characteristics in patients undergoing implantable cardioverter defibrillator implantation. J Cardiovasc Electrophysiol 1997;8:1209-17.
19. Min B, Kluger J, Kalus JS, Guertin D, McBride BF, White CM. The impact of catecholamines in patients with or without beta-blockers on the ventricular fibrillation cycle length and ventricular fibrillation cycle length variability. Ann Noninvasive Electrocardiol 2005;10:305-11.
20. Chorro F, Sanchez-Munoz JJ, Sanchis J, Cortina J, Butaller M, Guerrero J et al. Modifications in the evolution of the dominant frequency in ventricular fibrillation induced by amiodorone, diltiazem and flecainide. J Electrocardiol 1996;29:319-26.
21. Patwardhan A, Moghe S, Wang K, Leonelli F. Frequency modulation within electrocardiograms during ventricular fibrillation. Am J Physiol Heart Circ Physiol 2000; 279:H825-35.
22. Chorro F, Canoves J, Guerrero J, Mainar L, Sanchis J, Such L et al. Alteration of ventricular fibrillation by flecainide, verapamil, and sotalol: an experimental study. Circulation 2000;101:1606-15.